Univ.-Prof. Dipl.-Ing. Dr. Manfred Ogris
Manfred Ogris
41 - 60 out of 117
Mahrhauser D, Nagelreiter C, Gehrig S, Geyer A, Ogris M, Kwizda K et al. Assessment of Raman spectroscopy as a fast and non-invasive method for total stratum corneum thickness determination of pig skin. International Journal of Pharmaceutics. 2015;495(1):482-484. doi: 10.1016/j.ijpharm.2015.09.018

Huetz K, Mejias-Luque R, Farsakova K, Ogris M, Krebs S, Anton M et al. The stem cell factor SOX2 regulates the tumorigenic potential in human gastric cancer cells. Carcinogenesis. 2014 Apr;35(4):942-950. doi: 10.1093/carcin/bgt410


Gruenwald GK, Vetter A, Klutz K, Willhauck MJ, Schwenk N, Senekowitsch-Schmidtke R et al. EGFR-Targeted Adenovirus Dendrimer Coating for Improved Systemic Delivery of the Theranostic NIS Gene. Molecular Therapy - Nucleic Acids. 2013 Nov;2:131. doi: 10.1038/mtna.2013.58


Gruenwald GK, Vetter A, Klutz K, Willhauck MJ, Schwenk N, Senekowitsch-Schmidtke R et al. Systemic Image-Guided Liver Cancer Radiovirotherapy Using Dendrimer-Coated Adenovirus Encoding the Sodium Iodide Symporter as Theranostic Gene. The Journal of Nuclear Medicine. 2013 Aug;54(8):1450-1457. doi: 10.2967/jnumed.112.115493

Haase R, Magnusson T, Su B, Kopp F, Wagner E, Lipps H et al. Generation of a tumor- and tissue-specific episomal non-viral vector system. BMC Biotechnology. 2013 Jun 4;13:49. doi: 10.1186/1472-6750-13-49

Vetter A, Virdi KS, Espenlaub S, Roedl W, Wagner E, Kreppel F et al. Non-Covalent Coating of Adenoviral Vectors with PAMAM Dendrimer Conjugates Allows for CAR Independent Virus Uptake and Targeting to the EGF Receptor. Molecular Therapy. 2013 Jun;21(S1):S54. doi: 10.1016/S1525-0016(16)34469-0

Vetter A, Virdi KS, Espenlaub S, Roedl W, Wagner E, Holm PS et al. Adenoviral Vectors Coated with PAMAM Dendrimer Conjugates Allow CAR Independent Virus Uptake and Targeting to the EGF Receptor. Molecular Pharmaceutics. 2013 Feb;10(2):606-618. doi: 10.1021/mp300366f

Su B, Cengizeroglu A, Farkasova K, Viola JR, Anton M, Ellwart JW et al. Systemic TNF alpha Gene Therapy Synergizes With Liposomal Doxorubicine in the Treatment of Metastatic Cancer. Molecular Therapy. 2013 Feb;21(2):300-308. doi: 10.1038/mt.2012.229

Terziyska N, Alves CC, Groiss V, Schneider K, Farkasova K, Ogris M et al. In Vivo Imaging Enables High Resolution Preclinical Trials on Patients' Leukemia Cells Growing in Mice. PLoS ONE. 2012 Dec 31;7(12):52798. doi: 10.1371/journal.pone.0052798

Espenlaub S, Engler T, Johnston ICD, Vetter A, Ogris M, Kochanek S et al. Cationic synthetic polymers enable high-efficiency transduction of human hematopoietic progenitor cells by adenovirus vectors. Human Gene Therapy. 2012 Oct;23(10):A123-A124.

Gruenwald G, Vetter A, Klutz K, Willhauck M, Senekowitsch-Schmidtke R, Schwaiger M et al. EGFR-specific retargeting of a dendrimer-coated adenovirus carrying the sodium iodide symporter (NIS) for systemic radiovirotherapy of liver cancer. Human Gene Therapy. 2012 Oct;23(10):A93-A94.

Viola J, Grayeski P, Graf S, Kopp F, Wagner E, Besch R et al. Nonviral gene delivery to melanoma combining selective cellular uptake and tumour-specific transcription. Human Gene Therapy. 2012 Oct;23(10):A146-A146.

Mickler FM, Moeckl L, Ruthardt N, Ogris M, Wagner E, Braeuchle C. Tuning Nanoparticle Uptake: Live-Cell Imaging Reveals Two Distinct Endocytosis Mechanisms Mediated by Natural and Artificial EGFR Targeting Ligand. Nano Letters: a journal dedicated to nanoscience and nanotechnology. 2012 Jul;12(7):3417-3423. doi: 10.1021/nl300395q

Espenlaub S, Engler T, Johnston ICD, Vetter A, Ogris M, Kochanek S et al. Evaluation of the Cytokines SCF and IL-3 and Charged-Based Polymers for Targeting of Adenovirus Vectors to Human Hematopoietic Progenitor Cells. Molecular Therapy. 2012 May;20:S231-S231.

Abourbeh G, Shir A, Mishani E, Ogris M, Roedl W, Wagner E et al. PolyIC GE11 polyplex inhibits EGFR-overexpressing tumors. IUBMB Life. 2012 Apr;64(4):324-330. doi: 10.1002/iub.1002

Buyens K, De Smedt SC, Braeckmans K, Demeester J, Peeters L, van Grunsven LA et al. Liposome based systems for systemic siRNA delivery: Stability in blood sets the requirements for optimal carrier design. Journal of Controlled Release. 2012 Mar 28;158(3):362-370. doi: 10.1016/j.jconrel.2011.10.009

Klutz K, Willhauck MJ, Dohmen C, Wunderlich N, Knoop K, Zach C et al. Image-Guided Tumor-Selective Radioiodine Therapy of Liver Cancer After Systemic Nonviral Delivery of the Sodium Iodide Symporter Gene. Human Gene Therapy. 2011 Dec;22(12):1563-1574. doi: 10.1089/hum.2011.041


41 - 60 out of 117

Multimodal optical tomography to study pharmacokinetics and pharmacodynamics in cancer models

Ogris, M. (Speaker)

14 Jun 2024

Activity: Talks and presentationsTalk or oral contributionScience to Science


Polycation based mRNA delivery: bottlenecks and solutions

Ogris, M. (Speaker)

21 May 202423 May 2024

Activity: Talks and presentationsTalk or oral contributionScience to Science


Wie unser Immunsystem uns vor Tumoren schützt

Ogris, M. (Speaker)

5 Mar 2024

Activity: Talks and presentationsTalk or oral contributionScience to Public


Water-soluble NHC stabilized Gold Nanoparticles

Reithofer, M. (Speaker), Chin, J. M. (Contributor), Young, A. J. (Speaker), Sami, H. (Contributor), Eisen, C. (Contributor), Rubio, G. (Contributor), Tepe, N. (Contributor), Hofmann, T. (Contributor), Ogris, M. (Contributor) & Keppler, B. (Contributor)

11 Aug 2019

Activity: Talks and presentationsTalk or oral contributionScience to Science


Compact

Ogris, M. (Project Lead) & Urban, E. (Co-Lead)

1/11/1231/10/17

Project: Research funding


Department of Pharmaceutical Sciences

Josef-Holaubek-Platz 2 (UZA II)
1090 Wien
Room: 2D450

T: +43-1-4277-55551

m.ogris@univie.ac.at